Cite Filings / AQST / 0002012383-25-002498
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Aquestive Therapeutics, Inc. · Filed 2025-10-17 · Acc 0002012383-25-002498

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-07-27 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-10-17 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-10-17 4 Chief Operating Officer sold 67,575 shares at $7.01 ($473,701)
  • 2025-10-17 4 Chief Medical Officer sold 20,272 shares at $7.00 ($141,904)
  • 2025-10-17 4 Boyd Peter E. sold 10,000 shares at $7.00 ($70,000)
  • 2025-10-15 144 Sale of Securities
  • 2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…